{
    "2018-11-21": [
        [
            {
                "time": "2018-03-15",
                "original_text": "This Highly Rated Pharma Giant Is More Than Just A Diabetes Player",
                "features": {
                    "keywords": [
                        "Pharma Giant",
                        "Highly Rated",
                        "Diabetes"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Eli Lilly's Stock May Drop 7% Short-Term",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Drop",
                        "Short-Term"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Hot ETF Right Now?",
                "features": {
                    "keywords": [
                        "Franklin LibertyQ",
                        "ETF",
                        "Hot"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "equity"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly and Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Eli Lilly",
                        "Report"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}